Adpkd

Aquaretic medication In 2014, Japan was the first country in the world to approve a pharmacological treatment for ADPKD followed by Canada and Europe, which approved the drug tolvaptan for ADPKD patients in the beginning of 2015.

Besides TKV and HtTKV, the estimated glomerular filtration rate (eGFR) has also been tentatively used to predict the progression of ADPKD.

Kidney Transplant It is accepted that kidney transplantation is the preferred treatment for ADPKD patients with end-stage renal disease (ESRD).